A study on the antioxidant capacities of some benzimidazoles in rat tissues

Chemico-Biological Interactions

Volumn 113, Issue 1, 1998, Pages 65-77

  Can Eke, Benay ^a   Orhan Puskullu, M ^a   Buyukbingol, Erdem ^a   Iscan, Mumtaz ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Benzimidazole; Cytochrome P450 enzymes; Lipid peroxidation; Rat tissues

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; BUTYLCRESOL; CAFFEINE; CYTOCHROME P450 REDUCTASE; ETHOXYRESORUFIN DEETHYLASE; OXYGEN RADICAL; PENTOXYRESORUFIN DEALKYLASE; PROADIFEN;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; KIDNEY PARENCHYMA; LIPID PEROXIDATION; LIVER MICROSOME; LUNG PARENCHYMA; MALE; NONHUMAN; RAT;

ANIMALS; ANTIOXIDANTS; BENZIMIDAZOLES; BUTYLATED HYDROXYTOLUENE; CAFFEINE; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; ENZYME INHIBITORS; KIDNEY; LIPID PEROXIDATION; LUNG; MALE; MICROSOMES, LIVER; NADPH-FERRIHEMOPROTEIN REDUCTASE; PROADIFEN; RATS;

EID: 0031811878     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(98)00020-9     Document Type: Article

References (38)

1. C.A. Rice-Evans, A.T. Diplock, Techniques in Free Radical Research, Elsevier, Amsterdam, 1991, pp. 291.
2. Kappus H.A. A survey of chemicals inducing lipid peroxidation in biological systems. Chem. Phys. Lipids. 45:1987;105-115.
3. Sun Y. Free radicals, antioxidant enzymes and carcinogenesis. Free Radic. Biol. Med. 8:1990;583-599.
4. Y. Oyanagui, SOD and Active Oxygen Modulators. Pharmacology and Clinical Trials, Nihon-Igagukan, Tokyo, 1989, 290 p.
5. Sogawa S., Nihro Y., Ueda H., Miki T., Matsomota H., Satoh T. Protective effects of hydroxychalcones on free radical-induced cell damage. Biol. Pharm. Bull. 17:1994;251-256.
6. Hiramatsu M., Packer L. Antioxidant activity of retinoids. Methods Enzymol. 190:1990;273-280.
7. Samokyszyn V.M., Marnett L.J. Inhibitoin of microsomal lipid peroxidation by 13-cis-retinoic acid. Methods Enzymol. 190:1990;281-288.
8. Parke D.V., Ioannides C., Lewis D.F.V. The role of the cytochromes P450 in the detoxication and activation of drugs and other chemicals. Can. J. Physiol. Pharmacol. 69:1991;537-549.
9. Dix T.A., Aikens J. Mechanisms and biological relevance of lipid peroxidation initiation. Chem. Res. Toxicol. 6:1993;2-18.
10. Warner H.R. Superoxide dismutase, aging and degenerative disease. Free Radic. Biol. Med. 17:1994;249-258.
11. Gonder J.C., Proctor R.A., Will J.A. Genetic differences in oxygen toxicity are correlated with cytochrome P450 inducibility. Proc. Natl. Acad. Sci. USA. 82:1985;6315-6319.
12. Ekstrom G., Ingerman-Sundberg M. Mechanism of lipid peroxidation dependent upon cytochrome P450 LM2. Eur. J. Biochem. 158:1986;195-201.
13. Ohmari S., Misaizu T., Nakamura T., Takano N., Kitagawa H., Kitada M. Differential role in lipid peroxidation between rat P4501A1 and P4501A2. Biochem. Pharmacol. 46:1993;55-60.
14. Pederson T.L., Buege J.A., Aust S.D. Microsomal electron transport. The role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase in liver microsomal lipid peroxidation. J. Biol. Chem. 248:1973;7131-7141.
15. Svingen B.A., Buege J.A., O'Neal F.O., Aust S.D. The mechanism of NADPH-dependent lipid peroxidation. The propagation of lipid peroxidation. J. Biol. Chem. 254:1979;5892-5899.
16. Pearson J.O., Terelius Y., Ingelman-Sundberg M. Cytochrome P450-dependent formation of reactive oxygen radicals: isozyme-specific inhibition of P450-mediated reduction of oxygen and carbon tetrachloride. Xenobiotica. 20:1990;887-900.
17. Iscan M., Arinc E., Vural N., Iscan M.Y. In vivo effects of 3-methylcholanthrene, phenobarbital, pyrethrum and 2.4.5-T isooctylester on liver, lung and kidney microsomal mixed-function oxidase system of guinea-pig: a comparative study. Comp. Biochem. Physiol. 77C:1984;177-190.
18. Iscan M., Maines M.D. Differential regulation of heme and drug metabolism in rat testis and prostate: response to cis-platinium and human chorionic gonadotropin. J. Pharmacol. Exp. Ther. 253:1990;73-79.
19. Iscan M., Reuhl K., Weiss B., Maines M.D. Regional and subcellular distribution of cytochrome P450 dependent drug metabolism in monkey brain: the olfactory bulb and the mitochondrial fraction have high levels of activity. Biochem. Biophys. Res. Commun. 169:1990;858-863.
20. Paolini M., Mesirca R., Pozetti L., Sapone A., Cantelli-Forti G. Induction of CYP2B1 mediated pentoxyresofurin O-dealkylase activity in different species, sex and tissue by prototype 2B1 inducers. Chem.-Biol. Interact. 95:1995;127-139.
21. Murray M., Ryan A.J. The binding to oxidized cytochromes P-450 and inhibition of mixed-function oxidases by aryl-substituted benzimidazoles and related compounds. Chem.-Biol. Interact. 43:1983;341-351.
22. Iscan M.Y., Buyukbingol E., Iscan M., Sahin F., Safak C. Effects of 2-arylbenzimidazoles on rat hepatic microsomal monooxygenase system. Comp. Biochem. Physiol. 92C:1989;109-115.
23. Little P.J., Ryan A.J. Inhibitors of hepatic mixed function oxidazes. 4. Effects of benzimidazole and related compounds on aryl hydrocarbon hydroxylase activity from phenobarbitone and 3-methylcholanthrene induced rats. J. Med. Chem. 25:1982;622-626.
24. Dickens M., Bridges J.W. The relationship between the binding of 2-n-alkylbenzimidazoles to rat hepatic microsomal cytochrome P-450 and the inhibition of monooxygenation. Biochem. Pharmacol. 31:1982;1315-1320.
25. Wills E.D. Mechanism of lipid peroxide formation in animal tissues. Biochem. J. 99:1966;667-676.
26. Wills E.D. Lipid peroxide formation in microsomes. Relationship of hydroxylation to lipid peroxide formation. Biochem. J. 113:1969;333-341.
27. Bishayee S., Balasubramanian A.S. Lipid peroxide formation in rat brain. J. Neurochem. 18:1971;909-920.
28. Burke M.D., Thompson S., Elcombe C.R., Halpert J., Haaparante T., Mayer R.T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P450. Biochem. Pharmacol. 34:1985;3337-3345.
29. B.S.S. Masters, C.H. Williams Jr., H. Kamin, The preparation and properties of microsomal TPNH-cytochrome c reductase of pig liver, in: S.P. Colowick, N.O. Kaplan (Eds.), Methods in Enzymology, Academic Press, New York, 1967, pp. 565-573.
30. Lowry O.H., Rosenbrough H.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
31. I.C. Sipes, A.J. Gandolfi, Biotransformation of toxicants, in: M.O. Amdur, J. Doull, C.D. Klaassen (Eds.), Toxicology. The Basic Science of Poisons, Pergamon, New York, 1991, pp. 88-126.
32. Tassaneeyakul W., Mohamed Z., Birkett D.J., McManus M.E., Veronese M.E., Tukey R.H., Quattrochi L.C., Gonzales F.J., Miners J.O. Caffeine as a probe for human cytochromes P450: validation using cDNA expression, immunoinhibition and microsomal kinetic and inhibitor techniques. Pharmacogenetics. 2:1992;173-183.
33. Maenpaa J., Sigusch H., Raunio H., Syngelma T., Vuorela P., Vuorela H., Pelkonen O. Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem. Pharmacol. 45:1993;1035-1042.
34. Maines M.D. New developments in the regulation of heme metabolism and their implications. CRC Crit. Rev. Toxicol. 12:1984;241-314.
35. Karakaya A., Iscan M. Effect of cadmium on pulmonary and renal microsomal drug metabolizing enzymes on guinea-pig. Comp. Biochem. Physiol. 90C:1988;241-244.
36. Cinti D.L. Agents activating the liver microsomal mixed function oxidase system. Pharmacol. Ther. 2:1978;727-749.
37. Johnson E.F., Schwab G.E., Dieter H.H. Allosteric regulation of the 16-α-hydroxylation of progesterone as catalyzed by rabbit microsomal cytochrome P450 3b. J. Biol. Chem. 258:1983;2785-2788.
38. Nedelcheva V., Gut I. P450 in the rat and man: methods of investigation, substrate specifities and relevance to cancer. Xenobiotica. 24:1994;1151-1175.